When did LAVA Medtech Acquisition IPO?

LAVA Medtech Acquisition (LVACU) raised $100 million in an initial public offering on Wednesday, October 27th 2021. The company issued 10,000,000 shares at a price of $10.00 per share.

NASDAQ:LVACU

LAVA Medtech Acquisition (LVACU) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)

Free LVACU Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $10.40
▼
$10.40
50-Day Range: $10.40
▼
$10.43
52-Week Range: $9.92
▼
$10.68

Volume: 2 shs
Average Volume: 4,708 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get LAVA Medtech Acquisition alerts:

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

About LAVA Medtech Acquisition

LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP.

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

LVACU Stock News Headlines

October 3, 2023 | thestreet.com

LAVA Medtech Acquisition Corp. Warrants

April 20, 2022 | finance.yahoo.com

LAVA Medtech Acquisition Corp. Announces Closing of $115 Million Initial Public Offering Including Full Exercise of the Over-Allotment Option

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

April 20, 2022 | finance.yahoo.com

LAVA Medtech Acquisition Corp. Announces the Separate Trading of its shares of Class A Common Stock and Warrants, Commencing December 17, 2021

See More Headlines

Receive LVACU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LAVA Medtech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Finance
Industry: Shell Companies
Sub-Industry: N/A
Current Symbol: NASDAQ:LVACU
CUSIP: N/A
CIK: 1855450
Web: N/A
Phone: N/A
Fax: N/A
Employees: 2,021
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Anthony Natale M.B.A. (Age 48)
M.D., CEO & Director
Mr. Gerald A. Brunk M.B.A. (Age 53)
Pres & Director
Mr. Vasco Larcina C.A. (Age 57)
CPA, Chief Financial Officer
Dr. Jean Daniel Hetu M.B.A. (Age 64)
M.D., MBA, Exec. VP

Key Competitors

View All Competitors

LVACU Stock Analysis - Frequently Asked Questions

When did LAVA Medtech Acquisition IPO?: LAVA Medtech Acquisition (LVACU) raised $100 million in an initial public offering on Wednesday, October 27th 2021. The company issued 10,000,000 shares at a price of $10.00 per share.

This page (NASDAQ:LVACU) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

LAVA Medtech Acquisition (LVACU) Stock Price, News & Analysis

About LAVA Medtech Acquisition

LVACU Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

LVACU Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info